Jason B. Liu, MD, MS
Department of Surgical Oncology, Division of Surgery
About Dr. Jason Liu
Dr. Liu is a surgical oncologist at the University of Texas MD Anderson Cancer Center specializing in endocrine surgery (i.e., surgical conditions of the thyroid, parathyroid, and adrenal glands). His academic expertise lies in the implementation of patient-reported outcome measures (PROMs) for quality and performance improvement and to accelerate value-based healthcare transformation. He aims to harmonize and champion PROMs-related efforts across MD Anderson to improve patient-centered cancer care delivery and influence national standards in cancer care through evidence-based, patient-driven clinical excellence.
Present Title & Affiliation
Primary Appointment
Assistant Professor, Surgical Oncology, Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas
Adjunct Faculty, Health Services Research, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas
Adjunct Faculty, Patient-Reported Outcomes, Value, and Experience (PROVE) Center, Mass General Brigham, Boston, Massachusetts
Dual/Joint/Adjunct Appointment
Lead Faculty for Clinical Integration and Intelligent Care, Patient-Reported Outcomes, Value, and Experience (PROVE) Center, Mass General Brigham, Boston, Massachusetts
Assistant Professor, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Adjunct Faculty, Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2017 | Northwestern University, Chicago, Illinois, US, Health Services and Outcomes Research, MS |
| 2012 | University of Texas Southwestern Medical Center, Dallas, Texas, US, Medicine, MD |
| 2008 | Duke University, Durham, North Carolina, US, Biomedical Engineering, BSE |
Postgraduate Training
| 2021-2022 | Clinical Fellow, Endocrine Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania |
| 2020-2022 | Clinical Fellow, Complex General Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania |
| 2015-2018 | Research Fellow, Clinical Scholar in Residence, American College of Surgeons, Chicago, Illinois |
| 2012-2020 | Resident, General Surgery, University of Chicago Medicine, Chicago, Illinois |
Experience & Service
Faculty Academic Appointments
Adjunct Faculty, Patient-Reported Outcomes, Value, and Experience (PROVE) Center, Mass General Brigham, Boston, Massachusetts, 2025 - 2026
Assistant Professor, Harvard Medical School, Boston, Massachusetts, 2023 - 2025
Associate Surgeon, Surgery, Surgical Oncology, Brigham and Women's Hospital, Boston, Massachusetts, 2022 - 2025
Lead Faculty for Research and Innovation, Patient-Reported Outcomes, Value, and Experience (PROVE) Center, Mass General Brigham, Boston, Massachusetts, 2022 - 2025
Member of the Faculty, Harvard Medical School, Boston, Massachusetts, 2022 - 2023
Administrative Appointments/Responsibilities
Associate Director, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present
Interim Associate Director, Patient-Reported Outcomes, Value, and Experience (PROVE) Center, Mass General Brigham, Boston, Massachusetts, 2025 - 2025
Editorial Activities
Editorial Board Member, World Journal of Surgery, 2026 - Present
Associate Editor, Patient Safety in Surgery, 2025 - Present
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Liu JB, Chen YJ, Edelen MO, Pusic AL, Martin NE, Zeng C. Multilevel Factors Associated with Nonresponse to Patient-Reported Outcome Measures in Routine Radiation Oncology Care. medRxiv, 2026. e-Pub 2026. PMID: 42528581.
- Zeng C, Ahmed M, Chen YJ, Zhai S, Olisakwe SC, Dykes PC, Roberts TJ, Ufere NN, Davis ES, Zhou L, Edelen MO, Pusic AL, Kenzik KM, Lau-Min KS, Liu JB. Patient-reported symptom assessments and early chemotherapy discontinuation in routine gastrointestinal cancer care. Support Care Cancer 34(8), 2026. e-Pub 2026. PMID: 42449028.
- Moturu A, Hobika G, Liu JB, Temple LK, Cooper ZR, Hall BL, Pusic AL, Ko CY. Using CollaboRATE to Characterize Surgeon-Level Shared-Decision Making Performance. J Am Coll Surg 243(1):106-116, 2026. e-Pub 2026. PMID: 41773716.
- Liu JB, Yamashita TS, Rollins JL, Lee-Kim SH, Avula KC, Chacko R, Peek A, Williams LA, Zafereo ME, Maniakas A, Wang JR, Busaidy NL, Cabanillas ME, Castellanos LE, Chaudhri A, Dadu R, Hu MI, Vasquez CJ, Ying AK, Varghese JM, Sherman SI, Waguespack SG, Weitzman SP, Graham PH, Perrier ND, Shinn EH, Roth ME, Habra MA, Grubbs EG, Fisher SB. Patient-Reported Symptom Burden Among Thyroid Cancer Survivors: Retrospective Cohort Study. JCO Clin Cancer Inform 10(3):e2600041, 2026. e-Pub 2026. PMID: 42391597.
- Liu JB, He TX, Zeng C, Kaur MN, Tewari S, Zhang J, Edelen MO, Pusic AL, Bregar AJ, Melamed A, Sisodia RC. Association of surgical complexity with patient-reported outcomes among patients with ovarian cancer. Gynecol Oncol 208:106-112, 2026. e-Pub 2026. PMID: 42000384.
- Wong BO, Nader S, Wong JSM, Low XC, Farber ON, Liu JB, Lilley EJ. Patient-reported outcome measures used in studies of palliative surgery in cancer care: a scoping review. Ann Palliat Med 15(3):46, 2026. e-Pub 2026. PMID: 42273818.
- Soelling, SJ, Sulciner, ML, Saadat, L, Liu, JB, Raut, CP, Cho, NL. Improvements and shortcomings: Female representation in Endocrine Surgery and Surgical Oncology. American Journal of Surgery 254, 2026. e-Pub 2026. PMID: 41276447.
- Liu, JB, Dacier, BM, Dragonetti, BM, Meyers, PM, Sisodia, R, Park, LH, Pusic, AL, Ortega, G. Language concordance in the digital collection of patient-reported outcome measures. JAMIA Open 9(1), 2026. e-Pub 2026. PMID: 41509034.
- Zeng, C, Liu, JB, Ahmed, M, Ufere, NN, Chen, YJ, Zhai, S, He, T, Pusic, AL, Edelen, MO, Lau-Min, KS. Patient-reported symptom assessments and premature chemotherapy discontinuation in patients with gastrointestinal cancers. JCO Oncology Practice 21:383, 2025. e-Pub 2025.
- Liu JB, Moturu A, Temple LKF, Cooper ZR, Hall BL, Ko CY, Pusic AL. Over One-Third of Surgical Patients Report Inadequate Shared Decision-Making: Opportunities for Improvement From the ACS NSQIP PROMs Project. Ann Surg 282(3):449-459, 2025. e-Pub 2025. PMID: 40528763.
- Liu JB, Pusic AL, Temple LK, Moturu A, Hall BL, Ko CY. Evaluating Patient-Centered Surgical Care Quality Using Patient-Reported Measures of Shared Decision-Making. J Am Coll Surg 241(3):426-436, 2025. e-Pub 2025. PMID: 40197343.
- Sheu NO, Soelling SJ, Awtry JA, Mahvi DA, Nehs MA, Doherty GM, Chou SH, Liu JB, Cho NL. Streamlining Health Care Access for Patients With Primary Hyperparathyroidism: A Quality Improvement Pilot Program. J Surg Res 313:148-152, 2025. e-Pub 2025. PMID: 40664114.
- Zhang GQ, Farber ON, Lilley EJ, Akinbami FO, Fanning JE, Steinberg J, Bleday R, Pusic AL, Liu JB. Surgical Shared Decision-Making and Patient-Reported Outcomes. JAMA Surg 160(8):922-924, 2025. e-Pub 2025. PMID: 40601312.
- Zeng C, Lessani MN, Liu JB, Jarman MP, Ufere NN, Lau-Min KS, Meyers PM, Qiao S, Bryant AS, Kaur MN, Pusic AL, Li X, Li Z, Edelen MO. Impacts of Residential Segregation and Comorbidity on Racial Disparities in Acute Care Utilization. J Racial Ethn Health Disparities, 2025. e-Pub 2025. PMID: 40781218.
- Berlin NL, Chopra Z, Thirukumaran C, Tsai TC, Bates DW, Pusic AL, Liu JB. Low participation in voluntary period for patient-reported outcome performance measures for hip and knee replacement. Health Aff Sch 3(6):qxaf111, 2025. e-Pub 2025. PMID: 40503535.
- Morton CR, Cooper ZR, Bleday R, Fanning JE, Steinberg J, Zeng C, Pusic AL, Liu JB. Brief report: Relationships of frailty and age with nonresponse to patient reported outcome measures. Adv Patient Rep Outcomes 1(2), 2025. e-Pub 2025. PMID: 41356115.
- Enumah SJ, Chang DC, Cho NL, Cunningham CE, Doherty GM, Nehs MA, Randolph GW, Liu JB. Variation in commercial prices for thyroidectomy and parathyroidectomy at US hospitals. Am J Surg 241:116072, 2025. e-Pub 2025. PMID: 39561478.
- Patel VR, Adamson AS, Liu JB, Welch HG. Increasing Incidence and Stable Mortality of Pancreatic Cancer in Young Americans. Ann Intern Med 178(1):142-144, 2025. e-Pub 2025. PMID: 39556839.
- Kurtom S, Liu JB, Doerfler WR, Calcaterra M, McCoy KL, Sada A, Ramonell KM, Carty SE, Nikiforova MN, Nikiforov YE, Yip L. Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrence. Surgery 177:108838, 2025. e-Pub 2025. PMID: 39384477.
Patient Reviews
CV information above last modified September 25, 2026